Acorda Therapeutics, Inc. Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc.

ACOR

Peringkat dalam Saham #39163
Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering,... Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.
Harga Saham
$0.879
Terakhir disinkronkan: 2024-05-07
Kapitalisasi Pasar
$582.38K
Perubahan (1 hari)
9.88%
Perubahan (1 tahun)
8,690.00%
Negara
US
Perdagangan Acorda Therapeutics, Inc. (ACOR)

Kategori

Healthcare
Riwayat pemecahan saham untuk Acorda Therapeutics, Inc. (ACOR)
Saham Acorda Therapeutics, Inc. (simbol: ACOR) telah mengalami total 2 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Jun 05, 2023.
Satu lembar saham ACOR yang dibeli sebelum Jan 04, 2021 sekarang setara dengan 0.0083333333333333 lembar saham ACOR.
Daftar pemecahan saham
Tahun Pemecahan Kelipatan Kelipatan Kumulatif
2023-06-05 1:20 x0.05 x0.0083333333333333
2021-01-04 1:6 x0.16666666666667 x0.16666666666667
Pemecahan saham untuk perusahaan sejenis atau pesaing